ICU Medical, Inc. (FRA:IC7)

ICU Medical Statistics

Total Valuation

ICU Medical has a market cap or net worth of EUR 3.11 billion. The enterprise value is 4.03 billion.

Market Cap	3.11B
Enterprise Value	4.03B

Important Dates

The next estimated earnings date is Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	24.69M
Shares Outstanding	n/a
Shares Change (YoY)	+1.20%
Shares Change (QoQ)	-0.09%
Owned by Insiders (%)	1.22%
Owned by Institutions (%)	107.24%
Float	23.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	19.37
PS Ratio	1.57
PB Ratio	1.71
P/TBV Ratio	n/a
P/FCF Ratio	50.63
P/OCF Ratio	22.85
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.27, with an EV/FCF ratio of 65.72.

EV / Earnings	-642.42
EV / Sales	2.02
EV / EBITDA	13.27
EV / EBIT	35.88
EV / FCF	65.72

Financial Position

The company has a current ratio of 2.45, with a Debt / Equity ratio of 0.65.

Current Ratio	2.45
Quick Ratio	1.00
Debt / Equity	0.65
Debt / EBITDA	3.92
Debt / FCF	19.18
Interest Coverage	1.34

Financial Efficiency

Return on equity (ROE) is -0.35% and return on invested capital (ROIC) is 2.24%.

Return on Equity (ROE)	-0.35%
Return on Assets (ROA)	1.92%
Return on Invested Capital (ROIC)	2.24%
Return on Capital Employed (ROCE)	3.58%
Revenue Per Employee	131,843
Profits Per Employee	-418
Employee Count	15,000
Asset Turnover	0.55
Inventory Turnover	2.24

Taxes

In the past 12 months, ICU Medical has paid 31.65 million in taxes.

Income Tax	31.65M
Effective Tax Rate	124.73%

Stock Price Statistics

The stock price has decreased by -15.33% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-15.33%
50-Day Moving Average	109.48
200-Day Moving Average	115.95
Relative Strength Index (RSI)	66.99
Average Volume (20 Days)	11

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.75

Income Statement

In the last 12 months, ICU Medical had revenue of EUR 1.98 billion and -6.27 million in losses. Loss per share was -0.27.

Revenue	1.98B
Gross Profit	721.31M
Operating Income	110.20M
Pretax Income	25.38M
Net Income	-6.27M
EBITDA	283.14M
EBIT	110.20M
Loss Per Share	-0.27

Balance Sheet

The company has 258.85 million in cash and 1.18 billion in debt, giving a net cash position of -917.42 million.

Cash & Cash Equivalents	258.85M
Total Debt	1.18B
Net Cash	-917.42M
Net Cash Per Share	n/a
Equity (Book Value)	1.81B
Book Value Per Share	73.44
Working Capital	608.87M

Cash Flow

In the last 12 months, operating cash flow was 135.89 million and capital expenditures -74.56 million, giving a free cash flow of 61.33 million.

Operating Cash Flow	135.89M
Capital Expenditures	-74.56M
Free Cash Flow	61.33M
FCF Per Share	n/a

Margins

Gross margin is 36.47%, with operating and profit margins of 5.57% and -0.32%.

Gross Margin	36.47%
Operating Margin	5.57%
Pretax Margin	1.28%
Profit Margin	-0.32%
EBITDA Margin	14.32%
EBIT Margin	5.57%
FCF Margin	3.10%

Dividends & Yields

ICU Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.20%
Shareholder Yield	-1.20%
Earnings Yield	-0.20%
FCF Yield	1.98%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ICU Medical has an Altman Z-Score of 2.21 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.21
Piotroski F-Score	7